Cardinal Health completes sale of Cordis business to Hellman & Friedman
DUBLIN, Ohio, Aug. 2, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) and Hellman & Friedman (H&F) announced today the completion of the previously announced sale of Cardinal Health's Cordis business to H&F. The sale price of approximately$1 billion includes the buyer's assumption of certain lia...
Cardinal Health completes sale of Cordis business to Hellman & Friedman
DUBLIN, Ohio, Aug. 2, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) and Hellman & Friedman (H&F) announced today the completion of the previously announced sale of Cardinal Health's Cordis business to H&F. The sale price of approximately$1 billion includes the buyer's assumption of certain lia...
Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman
DUBLIN, Ohio, March 12, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately$1 billion, which includes buyer's assumption of certain liabilities and seller's retention o...
Cardinal Health Announces New Chinese Name 'Jia De Nuo'
BEIJING, March 30, 2019 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today unveiled its new Chinese name –Jia De Nuo at gathering of China's leading cardiologists inBeijing. In Chinese, "Jia" means auspicious and happy, "De" represents ethics, and "Nuo" is promise, which reflects Cardinal Healt...
Cardinal Health Completes Acquisition of Medtronic's Patient Recovery Business
DUBLIN, Ohio, July 31, 2017 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that it has completed the acquisition of Medtronic's Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business for$6.1 billion. The acquisition was funded with a combination of$4.5 billion in n...
